Literature DB >> 854043

Semi-conservative deoxyribonucleic acid synthesis in unirradiated and ultraviolet-irradiated xeroderma pigmentosum and normal human skin fibroblasts.

J M Rudé, E C Friedberg.   

Abstract

Rates of semiconservative DNA synthesis have been investigated in asynchronous xeroderma pigmentosum (XP), XP variant, and normal human skin fibroblasts using the technique of cellular autoradiography. In unirradiated cells, no differences in DNA synthesis rates were detected among the three cell strains. Exposure to UV radiation caused the rate of DNA synthesis to decrease for at least three hours in all three cell strains. In the normal cell strain, recovery of the DNA synthetic rate occurred at later times following a UV fluence of 5 J/m2. At this same UV fluence, recovery was absent in classical XP cells during a 24 h post-irradiation period while it was slower than normal in XP variant cells. When the UV fluence to classical XP and XP variant cells was reduced so that survival in all three cell strains was approximately the same (25%), recovery of the DNA synthetic rate was similar in all three cell strains. These results are discussed in terms of current models of DNA replication in UV-irradiated cells and indicate: (1) that pyrimidine dimers are very effective blocks to DNA synthesis and (2) that there is no inherent defect in semi-conservative DNA synthesis in either classical XP or XP variant cells which is independent of a defect in DNA repair capacity.

Entities:  

Mesh:

Year:  1977        PMID: 854043     DOI: 10.1016/s0027-5107(77)80047-x

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  16 in total

1.  Recovery of DNA synthesis after ultraviolet irradiation of xeroderma pigmentosum cells depends on excision repair and is blocked by caffeine.

Authors:  S D Park; J E Cleaver
Journal:  Nucleic Acids Res       Date:  1979-03       Impact factor: 16.971

Review 2.  The human intra-S checkpoint response to UVC-induced DNA damage.

Authors:  William K Kaufmann
Journal:  Carcinogenesis       Date:  2009-09-30       Impact factor: 4.944

3.  Postreplication repair: questions of its definition and possible alteration in xeroderma pigmentosum cell strains.

Authors:  S D Park; J E Cleaver
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Two complementation groups of Fanconi's anemia differ in their phenotypic response to a DNA-crosslinking treatment.

Authors:  E Moustacchi; D Papadopoulo; C Diatloff-Zito; M Buchwald
Journal:  Hum Genet       Date:  1987-01       Impact factor: 4.132

5.  Sensitivity to ultraviolet radiation in a dominantly inherited form of xeroderma pigmentosum.

Authors:  F P Imray; A Hockey; W Relf; R G Ramsay; C Kidson
Journal:  J Med Genet       Date:  1986-02       Impact factor: 6.318

6.  Ultraviolet light-induced chromosomal aberrations in cultured cells from Cockayne syndrome and complementation group C xeroderma pigmentosum patients: lack of correlation with cancer susceptibility.

Authors:  L R Seguin; R E Tarone; K H Liao; J H Robbins
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

7.  Genetic heterogeneity in ataxia-telangiectasia studied by cell fusion.

Authors:  N G Jaspers; D Bootsma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  DNA semi-conservative synthesis in normal and Fanconi anemia fibroblasts following treatment with 8-methoxypsoralen and near ultraviolet light or with X-rays.

Authors:  E Moustacchi; C Diatloff-Zito
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells.

Authors:  J Houldsworth; M F Lavin
Journal:  Nucleic Acids Res       Date:  1980-08-25       Impact factor: 16.971

10.  DNA repair after ultraviolet irradiation of ICR 2A frog cells. Pyrimidine dimers are long acting blocks to nascent DNA synthesis.

Authors:  B S Rosenstein; R B Setlow
Journal:  Biophys J       Date:  1980-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.